切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2023, Vol. 17 ›› Issue (01) : 60 -64. doi: 10.3877/cma.j.issn.1674-1358.2023.01.010

所属专题: 经典病例

病例报告

儿童川崎病并发胆汁淤积和无菌性脑膜炎一例
张玉凤1, 徐鹏飞1, 唐甜甜1, 刘瑞清1, 万涵2,()   
  1. 1. 710003 西安市,西安市儿童医院感染二科
    2. 710021 西安市,西安市第三医院普外科
  • 收稿日期:2022-06-21 出版日期:2023-02-15
  • 通信作者: 万涵

A child of Kawasaki disease complicated with cholestasis and aseptic meningitis

Yufeng Zhang1, Pengfei Xu1, Tiantian Tang1, Ruiqing Liu1, Han Wan2,()   

  1. 1. Second Department of Infectious Diseases, Xi’an Children’s Hospital, Xi’an 710003, China
    2. Department of Hepatobiliary Surgery, The 521 Hospital of China Ordnance Industry, Xi’an 710065, China
  • Received:2022-06-21 Published:2023-02-15
  • Corresponding author: Han Wan
引用本文:

张玉凤, 徐鹏飞, 唐甜甜, 刘瑞清, 万涵. 儿童川崎病并发胆汁淤积和无菌性脑膜炎一例[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(01): 60-64.

Yufeng Zhang, Pengfei Xu, Tiantian Tang, Ruiqing Liu, Han Wan. A child of Kawasaki disease complicated with cholestasis and aseptic meningitis[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(01): 60-64.

目的

分析1例川崎病并发胆汁淤积和无菌性脑膜炎患者的临床特征,以提升临床对川崎病少见并发症的关注度。

方法

回顾性分析2021年8月9日西安市儿童医院收治的1例川崎病合并胆汁淤积及无菌性脑膜炎患儿的临床资料、诊疗经过和预后。

结果

患儿入院后血细胞分析提示白细胞(25.12 × 109/L)升高,中性粒细胞比率为85.6%,C-反应蛋白(CRP):159 mg/L,红细胞沉降率为77 mm/h,肝功能:总胆红素(150.3 μmol/L)和直接胆红素(117.4 μmol/L)水平显著升高,丙氨酸氨基转移酶(78 IU/L)和天门冬氨酸氨基转移酶(68 IU/L)水平轻微升高,总胆汁酸(143 μmol/L)水平升高。腹部CT显示胆囊体积显著增加,胆管无明显扩张。超声心动图显示双侧冠状动脉扩张。脑脊液检查发现其压力轻度升高,脑脊液细胞学、糖及氯化物均正常。脑部磁共振成像(MRI)和脑电图均正常。患儿诊断为川崎病合并胆汁淤积及无菌性脑膜炎,经静脉滴注丙种球蛋白2 g/kg抗炎、阿司匹林和双嘧达莫抗凝、注射用丁二磺酸腺苷蛋氨酸利胆退黄、甘露醇脱水降颅压等治疗后患儿体温正常,黄疸消退,精神正常,各项指标恢复正常,无后遗症。

结论

川崎病同时并发胆汁淤积和无菌性脑膜炎的病例临床较少见,易漏诊误诊而延误治疗。对患有胆汁淤积和(或)无菌性脑膜炎和不明原因发热5 d以上的儿童应警惕川崎病,早期诊断和及时治疗可减少川崎病的并发症。

Objective

To analyze a case of Kawasaki disease complicated with cholestasis and aseptic meningitis, and to raise the attention to the rare complications of Kawasaki disease.

Methods

The clinical data, diagnosis and treatment process and prognosis of a child with Kawasaki disease complicated with cholestasis and aseptic meningitis admitted to Xi’an Children’s Hospital on August 9th 2021 were analyzed, retrospectively.

Results

After admission, blood cell analysis showed that leukocytes (25.12 × 109/L) increased, neutrophil ratio 85.6%, C-reactive protein (CRP) 159 mg/L, ESR 77 mm/h, total bilirubin (150.3 μmol/L) and direct bilirubin (117.4 μmol/L) increased significantly, alanine aminotransferase (78 IU/L) and aspartate aminotransferase (68 IU/L) increased slightly, total bile acids (143 μmol/L) increased. Abdominal CT showed a significant increase in the volume of gallbladder and no significant expansion of bile duct. Echocardiography showed bilateral coronary artery dilatation. Cerebrospinal fluid examination showed that the pressure increased slightly, and cerebrospinal fluid cytology, sugar and chloride were normal. Brain magnetic resonance imaging (MRI) and electroencephalogram (EEG) were normal. The patient was diagnosed as Kawasaki disease with cholestasis and aseptic meningitis. After treatment with intravenous gamma globulin 2 g/kg for anti-inflammation, aspirin and dipyridamole anticoagulation and inhibition of platelet aggregation, ademetionine for promoting jaundice regression, mannitol for cranial pressure reduction, the temperature returned normal, jaundice subsided, and his spirit was normal. After reexamination, all indicators recovered to normal without sequelae.

Conclusions

Kawasaki disease complicated with cholestasis and aseptic meningitis is rare, which is easy to be misdiagnosed and delayed to receive treatment. Therefore, clinicians are reminded to be alert to Kawasaki disease for children with cholestasis and/or aseptic meningitis and unexplained fever for longer than 5 days. Early diagnosis and timely treatment can reduce the complications of Kawasaki disease.

表1 患儿血液指标
图1 本病例腹部超声注:A:显示肝脏回声均匀,未见肝内胆管扩张;B:显示胆囊体积增大,胆囊壁增厚
图2 本病例腹部计算机断层扫描(CT)注:胆囊体积显著增加,胆管无明显扩张
表2 患儿CSF指标
[1]
Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children[J]. Arerugi,1967,16(3):178-222.
[2]
Li D, Chen X, Li X, et al. Effectiveness and safety of dual antiplatelet therapy in coronary aneurysms caused by Kawasaki disease in children: study protocol for a multicenter randomized clinical trial[J]. Transl Pediatr,2021,10(7):1914-1923.
[3]
张新艳, 杨婷婷, 何婷, 等. 2012至2016年单中心川崎病流行病学及临床特征研究[J]. 中国循证儿科杂志,2018,13(6):427-433.
[4]
朱妍洁, 黄国英. 川崎病诊断中的生物标志物[J]. 国际儿科学杂志,2019,46(2):77-80.
[5]
赵峥山, 黄国英. 川崎病冠状动脉病变的遗传学研究进展[J]. 国际儿科学杂志,2018,45(5):329-332.
[6]
崔青, 沈捷. 川崎病冠状动脉病变的手术治疗[J]. 中华实用儿科临床杂志,2021,36(10):789-793.
[7]
Singh S, Gupta A, Jindal A, et al. Pulmonary presentation of Kawasaki disease-A diagnostic challenge[J]. Pediatr Pulmonol,2018,53(1):103-107.
[8]
Colomba C, La Placa S, Saporito L, et al. Intestinal involvement in kawasaki disease[J]. J Pediatr,2018,202:186-193.
[9]
Seerat I, Khan EUD, Atique M, et al. Clinical spectrum of chronic liver disease with final outcome in children at a tertiary centre: A single-centre study[J]. Pak J Med Sci,2021,37(3):680-683.
[10]
董琛, 黄志华. 婴儿胆汁淤积性肝病的诊断及鉴别诊断[J]. 中华实用儿科临床杂志,2018,33(19):1441-1447.
[11]
Zafar M, Farooq M, Butler-Manuel W, et al. Vanishing bile duct syndrome associated with non-hodgkin’s lymphoma and hepatitis E virus infection[J]. Cureus,14(1):e21328.
[12]
Ji SB, Lee SS, Jung HC, et al. A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy[J]. Clin Mol Hepatol,2016,22(3):396-399.
[13]
马晓瑞, 李红霞, 马利. 348例药物性肝损害的临床分析[J]. 西安交通大学学报(医学版),2021,42(6):909-914.
[14]
程丽. 药物性肝损害临床分析[D]. 山东大学,2016.
[15]
van Mil SW, van der Woerd WL, van der Brugge G, et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11[J]. Gastroenterology,2004,127(2):379-384.
[16]
Klomp LW, Vargas JC, van Mil SW, et al. Characterization of mutations in ATP8B1 associated with hereditary cholestasis[J]. Hepatology,40(1):27-38.
[17]
Wang H, Yang L, Wang J. Etiology of neonatal cholestasis after emerging molecular diagnostics[J]. Transl Pediatr,2022,11(3):359- 367.
[18]
Zissimopoulos A, Cassimos D, Deftereos S, et al. Hepatobiliary scan in Alagille syndrome; arteriohepatic dysplasia[J]. Hell J Nucl Med,2009,12(2):158-60.
[19]
王璐, 韩英. 原发性硬化性胆管炎诊治进展[J/CD]. 中国医学前沿杂志(电子版),2020,12(2):7-12.
[20]
宋佳, 尹凤荣, 王冬, 等. 伴肝内胆汁淤积的多系统朗格汉斯细胞组织细胞增生症[J]. 中华消化杂志,2020,40(10):704-708.
[21]
王策, 于宪一. 320例川崎病患儿临床特点及冠状动脉损伤的高危因素分析[J]. 中国小儿急救医学,2018,25(12):939-942, 947.
[22]
谢中国, 刘洋, 吴婷婷. 川崎病并发毛细血管渗漏综合征及肝内胆汁淤积一例[J]. 中华儿科杂志,2016,54(2):156-157.
[23]
Pratap K, Gardner LS, Gillis D, et al. Hepatic predominant presentation of Kawasaki disease in adolescence case report and review of literature[J]. BMC Gastroenterol,2020,20(1):352.
[24]
Cha S, Yoon M, Ahn Y, et al. Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease[J]. J Korean Med Sci. 2008;23(4):718-722.
[25]
Yi DY, Kim JY, Choi EY, et al. Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children[J]. BMC Pediatr,2014,14:51.
[26]
杜曾庆, 马越明, 王美芬, 等. 川崎病并发无菌性脑膜炎53例临床分析[J]. 中国小儿急救医学,2012,19(3):294-296.
[27]
中华医学会儿科学分会心血管学组, 中华医学会儿科学分会风湿学组, 中华医学会儿科学分会免疫学组, 中华儿科杂志编辑委员会. 川崎病诊断和急性期治疗专家共识[J]. 中华儿科杂志,2022,60(1):6-13.
[28]
王程浩, 刘芳. 川崎病所致冠状动脉病变的病理改变及结局[J]. 中华实用儿科临床杂志,2021,36(22):1757-1760.
[1] 金鑫, 谢卯, 刘芸, 杨操, 杨述华, 许伟华. 个性化股骨导向器辅助初次全髋关节置换的随机对照研究[J]. 中华关节外科杂志(电子版), 2023, 17(06): 780-787.
[2] 杜滨和, 徐楠, 杨云川, 崔培元. 5项改良衰弱指数预测胰十二指肠切除术近期预后的价值探讨[J]. 中华普通外科学文献(电子版), 2023, 17(06): 444-448.
[3] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[4] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[5] 杨体飞, 杨传虎, 陆振如. 改良无充气经腋窝入路全腔镜下甲状腺手术对喉返神经功能的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 74-77.
[6] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[7] 陈大敏, 曹晓刚, 曹能琦. 肥胖对胃癌患者手术治疗效果的影响研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 651-653.
[8] 曹智, 朱希望, 王尉, 张辉, 杨成林, 张小明. 经皮肾镜碎石取石术中不同肾盂内压力与围术期并发症相关性研究[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 616-620.
[9] 代格格, 杨丽, 胡媛媛, 周文婷. 手术室综合干预在老年腹股沟疝患者中的应用效果[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 759-763.
[10] 王敏, 蒋家斌, 李茂新. 预警宣教联合个性化疼痛管理对腹股沟疝手术患者的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 764-767.
[11] 戴玮, 江桂林, 车兆平, 张姣, 王星星, 赵海涛. 无缝手术护理在腹股沟疝腹腔镜手术围手术期的应用效果[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 778-781.
[12] 叶晋生, 路夷平, 梁燕凯, 于淼, 冀祯, 贺志坚, 张洪海, 王洁. 腹腔镜下应用生物补片修补直肠术后盆底缺损的疗效[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 688-691.
[13] 袁伟, 张修稳, 潘宏波, 章军, 王虎, 黄敏. 平片式与填充式腹股沟疝修补术的疗效比较[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 697-701.
[14] 夏松, 姚嗣会, 汪勇刚. 经腹腹膜前与疝环充填式疝修补术治疗腹股沟疝的对照研究[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 702-705.
[15] 王小娜, 谭微, 李悦, 姜文艳. 预测性护理对结直肠癌根治术患者围手术期生活质量、情绪及并发症的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 525-529.
阅读次数
全文


摘要